Drug intelligence / Profile preview

menadione

Development stage
Phase 1
Modality
Small Molecules
Administration
Oral, Intramuscular, Subcutaneous, Intravenous
01

Overview

Menadione is a synthetic lipid-soluble vitamin K analogue (vitamin K3) and a member of the 1,4-naphthoquinones. It acts as a provitamin that is converted in vivo to menaquinone (vitamin K2), an active form of vitamin K. Menadione serves as an essential cofactor in the hepatic synthesis of prothrombin (factor II) and other clotting factors (VII, IX, X), facilitating gamma-carboxylation necessary for blood coagulation. It has been used as a nutritional supplement and for treating hypoprothrombinemia due to vitamin K deficiency. Menadione also exhibits roles as an angiogenesis inhibitor and antineoplastic agent in research settings[1][2][3][7]. Its use in humans is limited due to potential toxicity at high doses; it remains approved primarily for veterinary use or animal feed supplementation[4].

Brand names
Vitamin K3Vit K3
Other names
2-methyl-1,4-naphthoquinone2-methyl-1,4-naphthochinon2-methyl-1,4-naphthalenedionemenapthenemenapthone
02

Targets

AOX1 (Aldehyde oxidase 1)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)CYP1A2 (Cytochrome P450 1A2)

Beyond the preview

Go deeper on menadione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on menadione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call